Silvia Roman
Postdoctoral Researcher at Institute for Transfusion Medicine and Gene Therapy - University of Freiburg
Biochemistry as undergraduate study concluded in 2014 (National University of Asuncion, Paraguay). Master in Molecular Biotecnology concluded in 2016 (University of Barcelona, Spain). PhD in Natural Sciences concluded in 2022 (University of Freiburg, Germany). Currently working as a Postdoctoral Researcher at the University of Freiburg focusing on improving the cytotoxicity and persistence of CAR T cells.
GENAP Summit is a brand owned by EPM Group, registered company in Portugal. EU VAT ID PT513501312